Insilico Medicine
Owen Wu is a Business Operations Specialist at Insilico Medicine since June 2023, focusing on AI-driven drug discovery. Prior experience includes roles as a Part Time Data Analyst at Deloitte from December 2022 to June 2023, a Private Equity Fall Analyst at Triple Peak Capital from August 2022 to January 2023, and a Strategy Consulting Intern at Strategy& in the summer of 2021. Additionally, Owen held a Consulting Intern position at Bain & Company from June 2020 to November 2020. Educational qualifications consist of a Bachelor's degree in Econometrics and Quantitative Economics from New York University, a minor in Business Studies from NYU Stern School of Business, a study away program in Business, Management, Marketing, and Related Support Services at NYU Shanghai, and a high school diploma from Cranbrook Schools.
This person is not in any teams
This person is not in any offices
Insilico Medicine
2 followers
Insilico Medicine is an artificial intelligence company headquartered in Hong Kong, with R&D and management resources in the USA, Belgium, Russia, UK, Taiwan, and China sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through excellence in biomarker discovery, drug development, digital medicine, and aging research.